Position in CATX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$884,585
+$678,223 QoQ
Shares Held
212,131
+182.7% QoQ
Ownership
0.186%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CATX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026CITIGROUP INC holds $1,237,245,194 across 101 Medical Devices names. CATX ranks #32 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,165,231 | $222,304,264 | |
| 2 | PEN |
Penumbra Inc
|
620,943 | $203,899,052 | |
| 3 | SYK |
Stryker Corp
|
385,344 | $126,620,183 | |
| 4 | MDT |
Medtronic plc
|
1,337,911 | $115,929,987 | |
| 5 | BSX |
Boston Scientific Corp
|
1,576,640 | $98,934,159 | |
| 6 | MASI |
Masimo Corp
|
533,388 | $94,873,723 | |
| 7 | EW |
Edwards Lifesciences Corp
|
789,574 | $63,229,084 | |
| 8 | DXCM |
Dexcom Inc
|
834,087 | $52,380,663 |
All Filings in CATX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $884,585 | 212,131 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $206,362 | 75,041 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $429,806 | 125,308 | Shares | Defined | 2025-11-10 | |
| 2025-06-30 | $332,131 | 96,550 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $85,924 | 40,340 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $144,318 | 45,241 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $521,544 | 39,067 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $102,740 | 10,305 | Shares | Defined | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||